Mixed hyperlipidemia is a condition where both your LDL cholesterol and triglycerides are elevated at the same time. Unlike conditions that raise just one type of blood fat, mixed hyperlipidemia pushes up multiple lipid levels simultaneously, which significantly increases cardiovascular risk. It’s one of the most common inherited lipid disorders, though lifestyle factors like diet and obesity can trigger or worsen it.
How It Differs From High Cholesterol Alone
Standard high cholesterol typically means elevated LDL (the “bad” cholesterol) with triglycerides in a normal range. Mixed hyperlipidemia raises both. Diagnostic thresholds are LDL cholesterol above 160 mg/dL and triglycerides above 200 mg/dL, though borderline values of LDL above 130 mg/dL and triglycerides above 150 mg/dL can also signal the condition, especially when lipid levels fluctuate over time. HDL cholesterol (the “good” kind) is often low as well, compounding the problem.
One hallmark that sets mixed hyperlipidemia apart is its variability. Your lipid profile can shift between visits. One blood draw might show mostly high cholesterol, while the next shows high triglycerides, and a third shows both. This shifting pattern is actually a key diagnostic clue, and doctors may order lipid panels several months apart to confirm it.
What Causes It
The most well-known form is familial combined hyperlipidemia, which runs in families and affects roughly 1 to 2 percent of the general population. The core problem is that the liver overproduces particles that carry cholesterol and triglycerides through the bloodstream. At the same time, the body is slower to clear these particles, so they build up. A blood marker called apolipoprotein B (apoB), which reflects the total number of these harmful particles, tends to run above 125 mg/dL in people with the familial form.
The genetics behind it are complex. Unlike some inherited cholesterol disorders caused by a single gene, familial combined hyperlipidemia involves multiple genes interacting with each other and with lifestyle factors. That means two siblings can inherit the same genetic predisposition and have very different lipid profiles depending on their weight, diet, and activity level.
You don’t need a genetic predisposition to develop mixed hyperlipidemia. Several conditions and habits can push both cholesterol and triglycerides into unhealthy territory: obesity, physical inactivity, excess alcohol intake, high-carbohydrate diets, type 2 diabetes, chronic kidney disease, and nephrotic syndrome. Certain medications, including corticosteroids and estrogen-based therapies, can also contribute. In practice, many people have a combination of genetic susceptibility and lifestyle factors working together.
Why It’s a Serious Cardiovascular Risk
Mixed hyperlipidemia is not just “slightly worse” than having one elevated lipid. A 15-year follow-up study found that people with familial combined hyperlipidemia had a cardiovascular disease incidence of 23.6%, compared to 4.7% in a control group. That translates to roughly a fivefold higher risk of heart attack, stroke, or other cardiovascular events, even after adjusting for other risk factors like blood pressure and smoking.
The reason the risk is so amplified is that elevated triglycerides and elevated LDL damage arteries through different but overlapping mechanisms. High LDL deposits cholesterol in artery walls. High triglycerides promote inflammation and contribute to the formation of small, dense LDL particles, which penetrate artery walls more easily than larger LDL particles. Together, they accelerate the buildup of plaque in ways that neither would alone.
Symptoms and How It’s Detected
Mixed hyperlipidemia is almost always silent. Most people discover it through a routine blood test. There are no day-to-day symptoms that would tip you off, which is why regular lipid panels matter, especially if you have a family history of high cholesterol, heart disease, or early heart attacks.
In rare cases with extremely high triglycerides (typically above 1,500 mg/dL), small red or yellow bumps called eruptive xanthomas can appear on the skin, most commonly on the backs of the arms, thighs, and buttocks. These are 1 to 3 millimeters in size and tend to cluster together. If you notice skin bumps like this, especially alongside risk factors like heavy alcohol use or uncontrolled diabetes, a lipid panel can determine whether triglycerides are involved.
Dietary Changes That Help Both Numbers
Managing mixed hyperlipidemia through diet is tricky because the standard advice for cholesterol (cut saturated fat) and the standard advice for triglycerides (cut sugar and refined carbs) can sometimes feel contradictory. Cutting fat and replacing it with carbohydrates, for instance, can actually raise triglycerides.
Research on dietary management of combined hyperlipidemia points to the Mediterranean diet as particularly well suited. The emphasis on olive oil, fish, vegetables, legumes, and whole grains provides monounsaturated fats (which help both lipid types) while naturally limiting refined carbohydrates and saturated fat. The general targets are keeping total fat intake around 30% of daily calories while favoring monounsaturated sources over saturated ones.
Weight loss, even modest amounts, makes a measurable difference. Studies show that losing weight can reduce cholesterol by about 10% and triglycerides by roughly 30%. The triglyceride drop is especially notable because triglycerides respond more dramatically to weight changes than cholesterol does. That said, the long-term effects of weight loss on lipids tend to be moderate, which is why most people with mixed hyperlipidemia also need medication.
How It’s Treated With Medication
Statins are the first-line treatment. They primarily lower LDL cholesterol but also reduce triglycerides modestly, making them a reasonable starting point for mixed hyperlipidemia. Current guidelines from the American Heart Association and American College of Cardiology set specific targets depending on your overall cardiovascular risk. For people at intermediate risk, the goal is LDL below 100 mg/dL. For those at high risk or with existing heart disease, the target drops to below 70 mg/dL or even below 55 mg/dL.
When statins alone aren’t enough, combination therapy becomes important. For mixed hyperlipidemia specifically, adding a fibrate to a statin is often the better choice compared to other add-on options. Fibrates target triglycerides directly and also raise HDL cholesterol. Clinical trials show that combining a moderate-dose statin with a fibrate significantly reduces both LDL and triglycerides while boosting HDL, a combination effect that matches the mixed nature of the disorder. Another add-on option, ezetimibe (which blocks cholesterol absorption in the gut), pairs well with statins for additional LDL lowering but does less for triglycerides.
The combination of a statin and fibrate does carry a slightly elevated risk of muscle damage, a condition called myopathy that in rare cases can progress to a serious breakdown of muscle tissue. Risk factors for this complication include older age, kidney or liver disease, diabetes, and hypothyroidism. One specific fibrate, gemfibrozil, interferes with how the body processes statins and raises this risk more than fenofibrate does. For that reason, fenofibrate is the preferred fibrate when combining with a statin. In people without multiple other health conditions, the combination generally has a low incidence of muscle problems.
Non-HDL Cholesterol: The Number to Watch
If you have mixed hyperlipidemia, your doctor may focus on a measurement called non-HDL cholesterol in addition to (or instead of) LDL alone. Non-HDL cholesterol captures everything that’s not “good” cholesterol, including LDL, VLDL, and triglyceride-rich particles. It gives a more complete picture of cardiovascular risk when triglycerides are elevated, because standard LDL calculations become less accurate at higher triglyceride levels.
The 2026 ACC/AHA guidelines set non-HDL targets 30 points above the corresponding LDL target. So if your LDL goal is below 100 mg/dL, your non-HDL goal is below 130 mg/dL. If your LDL goal is below 70 mg/dL, non-HDL should be below 100 mg/dL. You can calculate your non-HDL cholesterol yourself from a standard lipid panel: take your total cholesterol and subtract your HDL. The number you get is your non-HDL cholesterol.